Safglim VG2 Tablet 10 Tablets

Safglim VG2 Tablet 10 Tablets

Prescription drug
Manufacturer / Marketer : MEXICAN WAVE PHARMA
About: Safglim VG2 Tablet is an oral antidiabetic combination used in adults with type 2 diabetes mellitus when diet, exercise and single‑drug therapy do not provide adequate control. It contains glimepiride, metformin and voglibose to target fasting as well as post‑meal blood glucose levels.
Usage Instructions Take the tablet with or after meals as directed by your diabetologist, usually once or twice daily. Swallow whole with water and do not skip meals after taking to avoid hypoglycaemia.
Benefits Helps control overall blood sugar and reduces the risk of long‑term complications such as kidney damage, nerve problems and eye disease when combined with lifestyle measures. Combines three agents in one tablet to simplify therapy and improve adherence.
How it Works Glimepiride stimulates pancreatic insulin secretion, metformin reduces hepatic glucose production and improves insulin sensitivity, and voglibose delays intestinal carbohydrate absorption. Their complementary mechanisms provide better glycaemic control throughout the day.
Side Effects Common side effects include hypoglycaemia, nausea, diarrhoea, abdominal pain, headache and flatulence. Seek medical help for severe low sugar, lactic acidosis symptoms (deep breathing, muscle pain, extreme weakness) or allergic reactions.
Safety Advice Contraindicated in type 1 diabetes, severe kidney or liver impairment and diabetic ketoacidosis. Regular blood sugar and renal function monitoring, avoidance of alcohol excess and adherence to diet and exercise are essential.
Storage Store at room temperature in a dry place away from light and moisture. Keep out of reach of children.
₹99.19 MRP: ₹107.81 Save ₹8.62 (7%)
Inclusive of all taxes
Quantity

Expiry Icon
Fresh Stock
Guaranteed
Return Icon
Secure & Hygienic
Packaging
Authentic Icon
Verified & Trusted
Supplements
Quality Icon
Secure
Payment
About: Safglim VG2 Tablet is an oral antidiabetic combination used in adults with type 2 diabetes mellitus when diet, exercise and single‑drug therapy do not provide adequate control. It contains glimepiride, metformin and voglibose to target fasting as well as post‑meal blood glucose levels.
Usage Instructions Take the tablet with or after meals as directed by your diabetologist, usually once or twice daily. Swallow whole with water and do not skip meals after taking to avoid hypoglycaemia.
Benefits Helps control overall blood sugar and reduces the risk of long‑term complications such as kidney damage, nerve problems and eye disease when combined with lifestyle measures. Combines three agents in one tablet to simplify therapy and improve adherence.
How it Works Glimepiride stimulates pancreatic insulin secretion, metformin reduces hepatic glucose production and improves insulin sensitivity, and voglibose delays intestinal carbohydrate absorption. Their complementary mechanisms provide better glycaemic control throughout the day.
Side Effects Common side effects include hypoglycaemia, nausea, diarrhoea, abdominal pain, headache and flatulence. Seek medical help for severe low sugar, lactic acidosis symptoms (deep breathing, muscle pain, extreme weakness) or allergic reactions.
Safety Advice Contraindicated in type 1 diabetes, severe kidney or liver impairment and diabetic ketoacidosis. Regular blood sugar and renal function monitoring, avoidance of alcohol excess and adherence to diet and exercise are essential.
Storage Store at room temperature in a dry place away from light and moisture. Keep out of reach of children.

Related Products